Cannabis Testing Market is Expected to Reach $4.0 billion | MarketsandMarkets™

Chicago, June 11, 2024 (GLOBE NEWSWIRE) — Cannabis Testing market in terms of revenue was estimated to be worth $1.8 billion in 2024 and is poised to reach $4.0 billion by 2029, growing at a CAGR of 17.2% from 2024 to 2029 according to a latest report published by MarketsandMarkets™.

The growth of the market is driven by regulatory shifts favoring legalization, propelling companies to adhere to stringent quality and safety standards. Moreover, R&D investments by key players promote technical innovation thus boosting testing efficiency and accuracy.

Download an Illustrative overview:

Cannabis Testing Market Scope:

Report Coverage Details
Market Revenue in 2024 $1.8 billion
Estimated Value by 2029 $4.0 billion
Growth Rate Poised to grow at a CAGR of 17.2%
Market Size Available for 2022–2029
Forecast Period 2024–2029
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Product & Software, By Service & By End User
Geographies Covered North America, Europe, the Asia Pacific, Latin America and the Middle East & Africa
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity Untapped markets in emerging economies
Key Market Driver Increasing legalization of medical and recreational cannabis

Based on product & software, the cannabis testing market is broadly segmented into products (analytical instruments and consumables) and software. Cannabis testing products dominate the market, accounting for the largest share throughout the forecast period. This segment is also projected to register the highest growth rate. The high growth of this segment can be attributed to the rising demand for pesticide screening and potency labeling, leading to an increase in the need for analytical instruments and associated high-tech products and increases the demand for consumables used in cannabis testing.

Based on service, the cannabis testing market is broadly segmented into potency testing, terpene profiling, residual solvent analysis, microbial analysis, pesticide screening, heavy metal testing, and other services. In 2023, potency testing accounted for the largest share of the cannabis testing services market. The potency testing segment is growing at significant CAGR due to increased demand for accurate measurement of THC and CBD levels. This trend is led by companies like Kaycha Holdings LLC and SC Labs, and driven by regulatory requirements, consumer safety concerns, and the need for consistent product quality in both medical and recreational cannabis industries.

Based on end user, the cannabis testing market has been segmented into product & software end users and service end users. The service end users segment accounted for the largest share of the global cannabis testing market in 2023 and the highest CAGR over the forecast period. The dominant share of this segment can primarily be attributed to the increasing legalization of cannabis, rising consumer awareness of safety and quality, stringent regulatory standards, and advancements in testing technologies.

The key regional markets for the global cannabis testing market are North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. In 2023, North America commanded the largest share in the cannabis testing market in 2023 and is expected to grow at a significant CAGR during the forecast period. The market in this region is driven by the rising legalization of cannabis for both recreational and medical purposes all over North America and the increasing medical applications of cannabis.  For example, in May 2023, Biophore India Pharmaceuticals’ subsidiary Zenara Pharma received approval for the final product, Cannabidiol Oral Solution 100mg/ml, indicated for neuro disorders. This was a first-of-its-kind Cannabidiol-based product approval in India. The market is further driven by the presence of major cannabis giants such as Aurora Cannabis Inc., Medical Marijuana Inc., and Canopy Growth Corporation, who consistently invest and collaborate to develop new products.

Buy a Cannabis Testing Industry Report (378 Pages PDF with Insightful Charts, Tables, and Figures):

Prominent Players of Cannabis Testing Market:

  • Agilent Technologies, Inc. (US)
  • Shimadzu Corporation (Japan)
  • Thermo Fisher Scientific Inc. (US)
  • Danaher Corporation (US)
  • Waters Corporation (US)
  • Restek Corporation (US)
  • SGS SA (Switzerland)
  • Merck KGaA (Germany)
  • PerkinElmer, Inc. (US)
  • Hamilton Company (US)
  • Sigma Analytical Services (Canada)
  • SC Labs (US)
  • PharmLabs LLC (US)
  • MCS, Inc.  (US)
  • ProVerde Laboratories (US)
  • Eurofins Scientific (Luxembourg)
  • Green Leaf Lab, LLC (US)
  • Kaycha Holdings LLC (US)
  • Accelerated Technology Laboratories, Inc. (US)
  • Cloudlims (US)
  • Labware (US)
  • Lablynx Inc. (US)
  • Encore Labs LLC (US)
  • Trichome Analytical (US)
  • Green Scientific Labs (US)
  • Digipath, Inc. (US)
  • and Among others

This report categorizes the cannabis testing market into the following segments and subsegments:

By Product & Software

  • Products
    • Analytical Instruments
      • Chromatography Instruments
        • Liquid Chromatography
        • Gas Chromatography
        • Other Chromatography Instruments
      • Spectroscopy Instruments
        • Mass Spectrometry Instruments
        • Atomic Spectroscopy Instruments
      • Other Analytical Instruments
    • Consumables
      • Chromatography Columns
      • Standards And Crms
      • Sample Preparation Products
      • Other Consumables
  • Cannabis Testing Software

By service

  • Potency Testing
  • Terpene Profiling
  • Residual Solvent Analysis
  • Microbial Analysis
  • Pesticide Screening
  • Heavy Metal Testing
  • Other Services

By end user

  • Product & Software
    • Cannabis Testing Laboratories
      • Small-Scale Laboratories
      • Medium-Scale Laboratories
      • Large-Scale Laboratories
    • Research Institutes
  • Services
    • Cannabis Drug Manufacturers & Dispensaries
    • Cannabis Cultivators/Growers

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Request for FREE Sample Pages:

Key Market Stakeholders of the Cannabis Testing:

  • Cannabis Testing Product Manufacturing Companies
  • Regulatory Authorities
  • Cannabis Producers/Cultivators
  • Research & Development Companies
  • Biotechnology Companies
  • Research Laboratories & Academic Institutes.
  • Market Research & Consulting Firms
  • Testing Laboratories

Report Objectives:

  • To define, describe, and forecast the cannabis testing market by product & software, service, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall cannabis testing market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and analyze their market shares and core competencies2
  • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions.
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.

Get 10% Free Customization on this Report:

Related Reports:

Drug Screening Market

Clinical Chemistry Analyzers Market

Laboratory Proficiency Testing Market

Efficacy Testing Market

Life Science Instrumentation Market

Get access to the latest updates on Cannabis Testing Companies and Cannabis Testing Market Size

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.